Cite
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.
MLA
Rolland, Morgane, et al. “Increased HIV-1 Vaccine Efficacy against Viruses with Genetic Signatures in Env V2.” Nature, vol. 490, no. 7420, Oct. 2012, pp. 417–20. EBSCOhost, https://doi.org/10.1038/nature11519.
APA
Rolland, M., Edlefsen, P. T., Larsen, B. B., Tovanabutra, S., Sanders-Buell, E., Hertz, T., deCamp, A. C., Carrico, C., Menis, S., Magaret, C. A., Ahmed, H., Juraska, M., Chen, L., Konopa, P., Nariya, S., Stoddard, J. N., Wong, K., Zhao, H., Deng, W., & Maust, B. S. (2012). Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2. Nature, 490(7420), 417–420. https://doi.org/10.1038/nature11519
Chicago
Rolland, Morgane, Paul T. Edlefsen, Brendan B. Larsen, Sodsai Tovanabutra, Eric Sanders-Buell, Tomer Hertz, Allan C. deCamp, et al. 2012. “Increased HIV-1 Vaccine Efficacy against Viruses with Genetic Signatures in Env V2.” Nature 490 (7420): 417–20. doi:10.1038/nature11519.